Status:
WITHDRAWN
Antigen Rapid Test Screening to Prevent SARS-CoV-2 Transmission (COVID-19) at Mass Gathering Events.
Lead Sponsor:
Norwegian Institute of Public Health
Collaborating Sponsors:
University of Oslo
Conditions:
Covid19
Eligibility:
All Genders
18-44 years
Phase:
NA
Brief Summary
To investigate the impact of rapid antigen testing for Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2), the investigators plan to conduct a large trial to assess the impact of using rapi...
Detailed Description
To investigate the impact of rapid SARS-CoV-2 antigen testing on the incidence of COVID-19, the investigators plan to conduct a large trial to assess the impact of using rapid tests to screen people b...
Eligibility Criteria
Inclusion
- Aged 18-45 years
- Willingness to be randomised and to have a PCR-test taken a week after mass gathering event (both intervention and control groups)
Exclusion
- Vaccinated for COVID-19
- Having tested positive for SARS-CoV-2 the last 6 months
- Risk factors for severe COVID-19
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04898127
Start Date
May 1 2021
End Date
December 1 2021
Last Update
March 27 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.